The Effects of Synbiotic Supplementation on Carotid Intima-Media Thickness, Biomarkers of Inflammation, and Oxidative Stress in People with Overweight, Diabetes, and Coronary Heart Disease: a Randomized, Double-Blind, Placebo-Controlled Trial
- 298 Downloads
Synbiotics are known to exert multiple beneficial effects, including anti-inflammatory and antioxidant actions. The aim of this study was to evaluate the effects of synbiotic supplementation on carotid intima-media thickness (CIMT), biomarkers of inflammation, and oxidative stress in people with overweight, diabetes, and coronary heart disease (CHD). This randomized, double-blind, placebo-controlled trial was conducted and involved 60 people with overweight, diabetes, and CHD, aged 50–85 years old. Participants were randomly allocated into two groups to take either synbiotic supplements containing three probiotic bacteria spices Lactobacillus acidophilus strain T16 (IBRC-M10785), Lactobacillus casei strain T2 (IBRC-M10783), and Bifidobacterium bifidum strain T1 (IBRC-M10771) (2 × 109 CFU/g each) plus 800 mg inulin or placebo (n = 30 each group) for 12 weeks. Fasting blood samples were taken at baseline and after the 12-week intervention period to determine metabolic variables. After the 12-week intervention, compared with the placebo, synbiotic supplementation significantly reduced serum high-sensitivity C-reactive protein (hs-CRP) (− 3101.7 ± 5109.1 vs. − 6.2 ± 3163.6 ng/mL, P = 0.02), plasma malondialdehyde (MDA) (− 0.6 ± 1.0 vs. − 0.1 ± 0.3 μmol/L, P = 0.01), and significantly increased nitric oxide (NO) levels (+ 7.8 ± 10.3 vs. − 3.6 ± 6.9 μmol/L, P < 0.001). We did not observe any significant changes of synbiotic supplementation on other biomarkers of oxidative stress and CIMT levels. Overall, synbiotic supplementation for 12 weeks among people with overweight, diabetes, and CHD had beneficial effects on serum hs-CRP, plasma NO, and MDA levels; however, it did not have any effect on other biomarkers of oxidative stress and CIMT levels.
KeywordsSynbiotic supplementation Carotid intima-media thickness Inflammation Oxidative stress Type 2 diabetes mellitus Coronary heart disease
AF, FR, AS, MT-E, MS-E, and AK contributed in data collection and manuscript drafting. ZA assisted in conception, design, statistical analysis, and drafting of the manuscript. All authors confirmed the final version of the paper.
The current study was funded by a grant from the Vice-Chancellor for Research, KUMS, and Iran.
Compliance with Ethical Standards
Conflict of Interest
The authors declare that they have no conflict of interest.
For Studies with Human Subjects
All procedures followed in the paper were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008. Informed consent was obtained from all patients for being included in the study.
- 1.Mathieu P, Poirier P, Pibarot P, Lemieux I, Després J-P (2009) Visceral obesity: the link among inflammation, hypertension, and cardiovascular disease. Hypertension 53:577–584. https://doi.org/10.1161/HYPERTENSIONAHA.108.110320 CrossRefGoogle Scholar
- 2.Cordero A, Lopez-Palop R, Carrillo P, Moreno-Arribas J, Bertomeu-Gonzalez V, Frutos A, Garcia-Carrilero M, Gunturiz C, Bertomeu-Martinez V (2016) Comparison of long-term mortality for cardiac diseases in patients with versus without diabetes mellitus. Am J Cardiol 117:1088–1094. https://doi.org/10.1016/j.amjcard.2015.12.057 CrossRefGoogle Scholar
- 3.Lewis CE, McTigue KM, Burke LE, Poirier P, Eckel RH, Howard BV, Allison DB, Kumanyika S, Pi-Sunyer FX (2009) Mortality, health outcomes, and body mass index in the overweight range: a science advisory from the American Heart Association. Circulation 119:3263–3271. https://doi.org/10.1161/CIRCULATIONAHA.109.192574 CrossRefGoogle Scholar
- 4.Bayanfar Z, Sadeghi M, Heidari R, Gharipour M, Talaie M, Sedaghat A (2014) Carotid intima-media thickness and plasma fibrinogen among subjects with metabolic syndrome: Isfahan cohort study, Iran. ARYA Atheroscler 10:238–243Google Scholar
- 7.Mangili A, Polak JF, Quach LA, Gerrior J, Wanke CA (2011) Markers of atherosclerosis and inflammation and mortality in patients with HIV infection. Atherosclerosis 214:468–473. https://doi.org/10.1016/j.atherosclerosis.2010.11.013 CrossRefGoogle Scholar
- 9.Ahmadi S, Jamilian M, Tajabadi-Ebrahimi M, Jafari P, Asemi Z (2016) The effects of synbiotic supplementation on markers of insulin metabolism and lipid profiles in gestational diabetes: a randomised, double-blind, placebo-controlled trial. Br J Nutr 116:1394–1401. https://doi.org/10.1017/S0007114516003457 CrossRefGoogle Scholar
- 10.Mofidi F, Yari Z, Poustchi H, Merat S, Nourinayyer B, Malekzadeh R, Hekmatdoost A (2016) Effects of synbiotics supplementation in lean patients with nonalcoholic fatty liver disease: study protocol of a pilot randomized double-blind clinical trial. Arch Iran Med 19:282–284Google Scholar
- 11.Ebrahimi ZS, Nasli-Esfahani E, Nadjarzade A, Mozaffari-Khosravi H (2017) Effect of symbiotic supplementation on glycemic control, lipid profiles and microalbuminuria in patients with non-obese type 2 diabetes: a randomized, double-blind, clinical trial. J Diabetes Metab Disord 16:23. https://doi.org/10.1186/s40200-017-0304-8 CrossRefGoogle Scholar
- 12.Bahmani F, Tajadadi-Ebrahimi M, Kolahdooz F, Mazouchi M, Hadaegh H, Jamal AS, Mazroii N, Asemi S, Asemi Z (2016) The consumption of synbiotic bread containing lactobacillus sporogenes and inulin affects nitric oxide and malondialdehyde in patients with type 2 diabetes mellitus: randomized, double-blind, placebo-controlled trial. J Am Coll Nutr 35:506–513CrossRefGoogle Scholar
- 13.Tabrizi R, Moosazadeh M, Lankarani KB, Akbari M, Heydari ST, Kolahdooz F, Asemi Z (2017) The effects of synbiotic supplementation on glucose metabolism and lipid profiles in patients with diabetes: a systematic review and meta-analysis of randomized controlled trials. Probiotics Antimicrob Proteins. https://doi.org/10.1007/s12602-017-9299-1
- 14.Memarrast F, Ghafouri-Fard S, Kolivand S, Jafary-Nodooshan S, Neyazi N, Sadroddiny E, Motevaseli E (2017) Comparative evaluation of probiotics effects on plasma glucose, lipid, and insulin levels in streptozotocin-induced diabetic rats. Diabetes Metab Res Rev. https://doi.org/10.1002/dmrr.2912
- 15.Mazloom Z, Yousefinejad A, Dabbaghmanesh MH (2013) Effect of probiotics on lipid profile, glycemic control, insulin action, oxidative stress, and inflammatory markers in patients with type 2 diabetes: a clinical trial. Iran J Med Sci 38:38–43Google Scholar
- 16.D'Souza A, Fordjour L, Ahmad A, Cai C, Kumar D, Valencia G, Aranda JV, Beharry KD (2010) Effects of probiotics, prebiotics, and synbiotics on messenger RNA expression of caveolin-1, NOS, and genes regulating oxidative stress in the terminal ileum of formula-fed neonatal rats. Pediatr Res 67:526–531. https://doi.org/10.1203/PDR.0b013e3181d4ff2b CrossRefGoogle Scholar
- 19.Welles CC, Whooley MA, Karumanchi SA, Hod T, Thadhani R, Berg AH, Ix JH, Mukamal KJ (2014) Vitamin D deficiency and cardiovascular events in patients with coronary heart disease: data from the Heart and Soul Study. Am J Epidemiol 179:1279–1287. https://doi.org/10.1093/aje/kwu059 CrossRefGoogle Scholar
- 20.Soccol CR, Vandenberghe LPS, Spier MR, Medeiros ABP, Yamaguishi CT, Lindner JDD, Pandey A, Thomaz-Soccol V (2010) The potential of probiotics: a review. Food Technol Biotechnol 48:413–434Google Scholar
- 21.Mohammadi AA, Jazayeri S, Khosravi-Darani K, Solati Z, Mohammadpour N, Asemi Z, Adab Z, Djalali M, Tehrani-Doost M, Hosseini M, Eghtesadi S (2016) The effects of probiotics on mental health and hypothalamic-pituitary-adrenal axis: a randomized, double-blind, placebo-controlled trial in petrochemical workers. Nutr Neurosci 19:387–395CrossRefGoogle Scholar
- 25.Beutler E, Gelbart T (1985) Plasma glutathione in health and in patients with malignant disease. J Lab Clin Med 105:581–584Google Scholar
- 29.Asemi Z, Khorrami-Rad A, Alizadeh SA, Shakeri H, Esmaillzadeh A (2014) Effects of synbiotic food consumption on metabolic status of diabetic patients: a double-blind randomized cross-over controlled clinical trial. Clin Nutr 33:198–203. https://doi.org/10.1016/j.clnu.2013.05.015 CrossRefGoogle Scholar
- 31.Styskal J, Van Remmen H, Richardson A, Salmon AB (2012) Oxidative stress and diabetes: what can we learn about insulin resistance from antioxidant mutant mouse models? Free Radic Biol Med 52:46–58. https://doi.org/10.1016/j.freeradbiomed.2011.10.441 CrossRefGoogle Scholar
- 32.Ceriello A, Esposito K, Piconi L, Ihnat MA, Thorpe JE, Testa R, Boemi M, Giugliano D (2008) Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients. Diabetes 57:1349–1354. https://doi.org/10.2337/db08-0063 CrossRefGoogle Scholar
- 36.Wang Y, Xie J, Li Y, Dong S, Liu H, Chen J, Zhao S, Zhang Y, Zhang H (2016) Probiotic Lactobacillus casei Zhang reduces pro-inflammatory cytokine production and hepatic inflammation in a rat model of acute liver failure. Eur J Nutr 55:821–831. https://doi.org/10.1007/s00394-015-0904-3 CrossRefGoogle Scholar
- 38.Yao J, Pan D, Zhao Y, Zhao L, Sun J, Wang Y, You QD, Xi T, Guo QL, Lu N (2014) Wogonin prevents lipopolysaccharide-induced acute lung injury and inflammation in mice via peroxisome proliferator-activated receptor gamma-mediated attenuation of the nuclear factor-kappaB pathway. Immunology 143:241–257. https://doi.org/10.1111/imm.12305 CrossRefGoogle Scholar
- 39.Kinoshita A, Onoda H, Imai N, Nishino H, Tajiri H (2015) C-reactive protein as a prognostic marker in patients with hepatocellular carcinoma. Hepato-Gastroenterology 62:966–970Google Scholar
- 42.Badehnoosh B, Karamali M, Zarrati M, Jamilian M, Bahmani F, Tajabadi-Ebrahimi M, Jafari P, Rahmani E, Asemi Z (2017) The effects of probiotic supplementation on biomarkers of inflammation, oxidative stress and pregnancy outcomes in gestational diabetes. J Matern Fetal Neonatal Med:1–9. https://doi.org/10.1080/14767058.2017.1310193
- 46.Jafarpour D, Shekarforoush SS, Ghaisari HR, Nazifi S, Sajedianfard J, Eskandari MH (2017) Protective effects of synbiotic diets of Bacillus coagulans, Lactobacillus plantarum and inulin against acute cadmium toxicity in rats. BMC Complement Altern Med 17:291. https://doi.org/10.1186/s12906-017-1803-3 CrossRefGoogle Scholar
- 47.Ebrahimi-Mameghani M, Sanaie S, Mahmoodpoor A, Hamishehkar H (2013) Effect of a probiotic preparation (VSL#3) in critically ill patients: a randomized, double-blind, placebo-controlled trial (Pilot Study). Pak J Med Sci 29:490–494Google Scholar
- 48.Lamprecht M, Bogner S, Schippinger G, Steinbauer K, Fankhauser F, Hallstroem S, Schuetz B, Greilberger JF (2012) Probiotic supplementation affects markers of intestinal barrier, oxidation, and inflammation in trained men; a randomized, double-blinded, placebo-controlled trial. J Int Soc Sports Nutr 9:45. https://doi.org/10.1186/1550-2783-9-45 CrossRefGoogle Scholar